1 completed, 1 recruiting, 1 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
Follow Nystagmus, Congenital: new trials by email Literature Review of Nystagmus, Congenital trials Research Report on Nystagmus, Congenital
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Genetic Studies of Strabismus, Nystagmus, and Associated Disorders whole genome sequencing or whole exome sequencing - Strabismus, Nystagmus, Congenital | Recruiting | Boston Children's Hospital | 400 | 2021-09-03 | 2025-12-12 | |
| Open-lable Extension Study on Safety and Efficacy of Neramexane to Treat Congenital and Acquired Nystagmus Neramexane mesylate - Nystagmus, Congenital, Nystagmus, Acquired | Phase 2 | Terminated | Merz Pharmaceuticals GmbH | 48 | 2009-05-01 | 2010-07-01 |
| Eye Muscle Surgery to Treat Congenital Nystagmus horizontal muscles of the eye will be cut and then reattached in the same position - Nystagmus | Phase 2 | Completed | National Eye Institute (NEI) | 15 | 1999-08-01 | 2008-03-04 |
Nystagmus, Pathologic (3) · Esotropia (1) · Exotropia (1) · Multiple Sclerosis (1) · Strabismus (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Cranial Nerve Diseases (3) · Eye Diseases (3) · Infant, Newborn, Diseases (3) · Nervous System Diseases (3) · Ocular Motility Disorders (3) · Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Demyelinating Autoimmune Diseases, CNS (1) · Demyelinating Diseases (1) · Immune System Diseases (1)
Exome Sequencing (1) · Whole Genome Sequencing (1)
Boston Children's Hospital (1) · Merz Pharmaceuticals GmbH (1) · National Eye Institute (NEI) (1)
United States (2) · United Kingdom (1)
R01EY032539 (1)